论文部分内容阅读
Phosphoinosilide 3-kinase(PI3K) is an attractive target to potentially treat a range of disease stales as illustrated by more than 15 inhibitors now in clinical trials.We disclose herein the discovery of a new class of fluoroquinolone derivatives having improved potency toward PI3K.